Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/09/21 → 31/12/24 |
Keywords
- Alzheimer's disease
- Neurodegenerative diseases
- Clinical trial
Clinical Trial Phase
- Phase II
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of AL002 in Participants with Early Alzheimer's Disease
- O'Brien, Terence (Primary Chief Investigator (PCI))
Project: Research